✦ DR. A.P.J. AKTU B.Pharm 2019-20 — Premium Study Notes, Diagrams & Resources ✦
V-Pharm
  • Home
  • Year I
  • Year II
  • Year III
  • Year IV
  • Pomodoro
✦ AKTU B.Pharm 2019-20 Syllabus

Master
Pharmacy
with Precision

Complete B.Pharm notes for all 8 semesters — structured unit-wise with diagrams, mnemonics, flowcharts, molecular structures and PDF downloads. Built on PCI Guidelines, AKTU Lucknow.

Explore Syllabus Start Study Session
⚕ V-Pharm
8Semesters
30+Subjects
150+Topics
50+Diagrams
100%Free
AKTU B.Pharm 2019-20

Complete Syllabus

BP101THuman Anatomy & Physiology I
  • Unit I: Cell structure, transport, division, tissue classification
  • Unit II: Integumentary system, skeletal system, muscle physiology
  • Unit III: Blood composition, hemopoiesis, coagulation, lymphatic system
  • Unit IV: Peripheral & autonomic nervous system, special senses
  • Unit V: Cardiovascular system, ECG, cardiac cycle, blood pressure
45 HrsSem 1
BP102TPharmaceutical Analysis I
  • Unit I: Techniques of analysis, standards, errors, Pharmacopoeia
  • Unit II: Acid-base titration, non-aqueous titration (Ephedrine HCl)
  • Unit III: Precipitation, complexometric, gravimetry, diazotization
  • Unit IV: Redox titrations — Cerimetry, Iodimetry, Iodometry
  • Unit V: Conductometry, Potentiometry, Polarography
45 HrsSem 1
BP103TPharmaceutics I
  • Unit I: History of pharmacy, Pharmacopoeias, dosage forms, posology
  • Unit II: Pharmaceutical calculations, powders, liquid dosage forms
  • Unit III: Monophasic & biphasic liquids, suspensions, emulsions
  • Unit IV: Suppositories, displacement value, incompatibilities
  • Unit V: Semisolid dosage forms — ointments, creams, gels
45 HrsSem 1
BP104TPharmaceutical Inorganic Chemistry
  • Unit I: Impurities, limit tests — Cl, SO4, Fe, As, Pb, Heavy metals
  • Unit II: Acids, bases, buffers, electrolytes, dental products
  • Unit III: GI agents — antacids, cathartics, antimicrobials
  • Unit IV: Expectorants, emetics, hematinics, antidotes, astringents
  • Unit V: Radiopharmaceuticals — α, β, γ radiation, I-131
45 HrsSem 1
BP201THuman Anatomy & Physiology II
  • Unit I: CNS — brain, spinal cord, neurotransmitters, action potential
  • Unit II: Digestive system, GIT anatomy, energetics (ATP, BMR)
  • Unit III: Respiratory & urinary system, nephrons, urine formation
  • Unit IV: Endocrine system — pituitary, thyroid, adrenal, pancreas
  • Unit V: Reproductive system, genetics, DNA, protein synthesis
45 HrsSem 2
BP202TPharmaceutical Organic Chemistry I
  • Unit I: Classification, IUPAC nomenclature, structural isomerism
  • Unit II: Alkanes, alkenes, conjugated dienes, Markownikoff/Anti-M
  • Unit III: Alkyl halides SN1/SN2, alcohols — ethanol, glycerol, propylene glycol
  • Unit IV: Carbonyl compounds — aldol, Cannizzaro, Benzoin, Perkin
  • Unit V: Carboxylic acids, acetic/citric/salicylic acid, amines
45 HrsSem 2
BP203TBiochemistry
  • Unit I: Biomolecules — carbohydrates, lipids, amino acids, ATP
  • Unit II: Carbohydrate metabolism — glycolysis, TCA, ETC, diabetes
  • Unit III: Lipid metabolism, cholesterol, amino acid catabolism, urea cycle
  • Unit IV: Nucleic acids, DNA replication, transcription, protein synthesis
  • Unit V: Enzyme kinetics — Michaelis-Menten, inhibitors, coenzymes
45 HrsSem 2
BP204TPathophysiology
  • Unit I: Cell injury, adaptation, inflammation, atherosclerosis
  • Unit II: CVS — hypertension, MI; Respiratory — asthma, COPD; Renal failure
  • Unit III: Anemia, diabetes, epilepsy, Parkinson, schizophrenia
  • Unit IV: IBD, jaundice, hepatitis A-F, rheumatoid arthritis, cancer
  • Unit V: Meningitis, TB, AIDS, STDs
45 HrsSem 2
BP301TPharmaceutical Organic Chemistry II
  • Unit I: Benzene — structure, aromaticity, Huckel's rule, EAS reactions
  • Unit II: Phenols, aromatic amines, diazonium salts, aromatic acids
  • Unit III: Fats and oils — hydrolysis, saponification, analytical constants
  • Unit IV: Carbohydrates — glucose, fructose, sucrose, starch, cellulose
  • Unit V: Amino acids, proteins, heterocyclic compounds
45 HrsSem 3
BP302TPhysical Pharmaceutics I
  • Unit I: States of matter, thermodynamics of solutions
  • Unit II: Surface & interfacial phenomena, adsorption, surfactants
  • Unit III: Viscosity, rheology — Newtonian and non-Newtonian flow
  • Unit IV: Disperse systems — colloids, suspensions, emulsions
  • Unit V: Complexation, protein binding, solubility enhancement
45 HrsSem 3
BP303TPharmaceutical Microbiology
  • Unit I: Microbial morphology, classification, staining techniques
  • Unit II: Culture media, sterilization methods, LAF, validation
  • Unit III: Immunity — innate, acquired; vaccines, immunoglobulins
  • Unit IV: Microbial limits, sterility testing, pyrogen testing
  • Unit V: Microbial assay of antibiotics and vitamins
45 HrsSem 3
BP304TPharmaceutical Engineering
  • Unit I: Flow of fluids, Reynold's number, Bernoulli's theorem
  • Unit II: Size reduction — ball mill, fluid energy mill, hammer mill
  • Unit III: Filtration — sand, sintered, membrane; centrifugation
  • Unit IV: Heat transfer, evaporation — single/multiple effect evaporators
  • Unit V: Drying — tray, spray, freeze dryer, fluidized bed dryer
45 HrsSem 3
BP401TPharmaceutical Organic Chemistry III
  • Unit I: Stereochemistry — chirality, R/S configuration, optical activity
  • Unit II: Organosulfur compounds, sulfonamides
  • Unit III: Organophosphorus compounds, pesticides
  • Unit IV: Heterocyclic — furan, thiophene, pyrrole, pyridine, indole
  • Unit V: Alkaloids — morphine, quinine, atropine, caffeine
45 HrsSem 4
BP402TMedicinal Chemistry I
  • Unit I: Drug design concepts — SAR, bioisosterism, prodrug
  • Unit II: Sedatives, hypnotics — barbiturates, benzodiazepines
  • Unit III: Analgesics — NSAIDs, opioids, local anesthetics
  • Unit IV: ANS drugs — adrenergic, cholinergic agents
  • Unit V: Antiepileptics, antiparkinsonian, antipsychotics
45 HrsSem 4
BP404TPharmacology I
  • Unit I: General pharmacology — routes, pharmacokinetics, receptor theory
  • Unit II: ANS pharmacology — sympathomimetics, parasympatholytics
  • Unit III: CVS drugs — antihypertensives, antianginals, antiarrhythmics
  • Unit IV: Autacoids — histamine, 5-HT, prostaglandins, NSAIDs
  • Unit V: Respiratory drugs — bronchodilators, antitussives, expectorants
45 HrsSem 4
BP405TPharmacognosy I
  • Unit I: Introduction, cultivation, collection, processing of crude drugs
  • Unit II: Classification — alphabetical, taxonomical, pharmacological
  • Unit III: Carbohydrates & lipid-containing drugs
  • Unit IV: Volatile oils — peppermint, eucalyptus, clove, turpentine
  • Unit V: Resins & resins combinations — colophony, podophyllum
45 HrsSem 4
BP501TMedicinal Chemistry II
  • Unit I: Antibacterials — sulfonamides, quinolones, fluoroquinolones
  • Unit II: Antibiotics — penicillins, cephalosporins, aminoglycosides
  • Unit III: Antifungals, antivirals, antimalarials — chloroquine, quinine
  • Unit IV: Antitubercular — INH, rifampicin, ethambutol, pyrazinamide
  • Unit V: Anticancer drugs — alkylating, antimetabolites, plant alkaloids
45 HrsSem 5
BP502TIndustrial Pharmacy I
  • Unit I: Tablets — types, excipients, direct compression, granulation
  • Unit II: Tablet coating — sugar, film, enteric coating; evaluation
  • Unit III: Capsules — hard & soft gelatin, filling, evaluation
  • Unit IV: Parenterals — LVP/SVP, formulation, sterilization, filling
  • Unit V: Ophthalmic, nasal, otic preparations
45 HrsSem 5
BP503TPharmacology II
  • Unit I: CNS pharmacology — general anesthetics, sedatives, hypnotics
  • Unit II: Antiepileptics, antiparkinsonian drugs, CNS stimulants
  • Unit III: Opioid analgesics, antipsychotics, antidepressants, antianxiety
  • Unit IV: GIT drugs — antiulcer, antiemetic, laxatives, antidiarrheal
  • Unit V: Hormones — insulin, oral hypoglycemics, thyroid, corticosteroids
45 HrsSem 5
BP504TPharmacognosy & Phytochemistry II
  • Unit I: Alkaloids — classification, biosynthesis, extraction methods
  • Unit II: Glycosides — cardiac, anthraquinone, saponin, cyanophoric
  • Unit III: Tannins, lignans, bitter principles, marine drugs
  • Unit IV: Plant growth regulators, phytoconstituents in cosmetics
  • Unit V: Biotransformation, tissue culture, plant biopesticides
45 HrsSem 5
BP505TPharmaceutical Jurisprudence
  • Unit I: Drugs & Cosmetics Act 1940 — schedules, licensing
  • Unit II: Pharmacy Act 1948, Pharmacy Council of India
  • Unit III: DPCO, Narcotic & Psychotropic Substances Act
  • Unit IV: Prevention of Cruelty to Animals Act, CDSCO, WHO-GMP
  • Unit V: Patent Act, Ethics in pharmacy, code of conduct
45 HrsSem 5
BP601TMedicinal Chemistry III
  • Unit I: Diuretics — thiazides, loop, potassium-sparing, carbonic anhydrase inhibitors
  • Unit II: Antihypertensives — ACE inhibitors, ARBs, calcium channel blockers
  • Unit III: Antihyperlipidemics — statins, fibrates, bile acid sequestrants
  • Unit IV: Anticoagulants, antifibrinolytics, antiplatelet agents
  • Unit V: Vitamins, antioxidants — ascorbic acid, tocopherols, retinoids
45 HrsSem 6
BP604TBiopharmaceutics & Pharmacokinetics
  • Unit I: Biopharmaceutics — absorption, ADME, BCS classification
  • Unit II: Pharmacokinetics — one/two compartment models, Vd, CL
  • Unit III: First-pass effect, bioavailability, bioequivalence
  • Unit IV: Non-linear kinetics, enzyme induction/inhibition
  • Unit V: Clinical PK — TDM, dosage regimen design, protein binding
45 HrsSem 6
BP606TQuality Assurance
  • Unit I: GMP concepts, WHO/ICH guidelines, cGMP
  • Unit II: GLP, GCP, validation — process, cleaning, analytical
  • Unit III: Quality management — TQM, ISO 9000, SOPs
  • Unit IV: Regulatory submissions — ANDA, NDA, CTD format
  • Unit V: Stability testing — ICH Q1A zones, accelerated studies
45 HrsSem 6
BP701TInstrumental Methods of Analysis
  • Unit I: UV-Visible spectroscopy — Beer-Lambert law, chromophores
  • Unit II: IR spectroscopy — functional group identification
  • Unit III: NMR — chemical shift, coupling constant, 1H and 13C NMR
  • Unit IV: Mass spectrometry — M+, fragmentation patterns
  • Unit V: Chromatography — HPLC, GC, TLC, ion exchange
45 HrsSem 7
BP702TIndustrial Pharmacy II
  • Unit I: Pilot plant scale-up — tablets, liquids, semisolids, parenterals
  • Unit II: Technology transfer, technology development
  • Unit III: Formulation challenges — poorly soluble drugs, SEDDS
  • Unit IV: Regulatory dossiers, IND, NDA submission process
  • Unit V: Controlled release systems — matrix, reservoir, osmotic pump
45 HrsSem 7
BP703TPharmacy Practice
  • Unit I: Hospital pharmacy — organization, formulary, drug procurement
  • Unit II: Clinical pharmacy — patient counseling, DUR, ADR monitoring
  • Unit III: Therapeutic drug monitoring, pharmacovigilance
  • Unit IV: Community pharmacy — OTC counseling, compounding
  • Unit V: Poison information, drug interactions, geriatric pharmacy
45 HrsSem 7
BP704TNovel Drug Delivery Systems
  • Unit I: NDDS rationale — controlled, sustained, targeted delivery
  • Unit II: Transdermal drug delivery — patches, permeation enhancers
  • Unit III: Liposomes, niosomes, microspheres, nanoparticles
  • Unit IV: Mucoadhesive, ocular, pulmonary drug delivery
  • Unit V: Targeted delivery — antibody conjugates, solid lipid NPs
45 HrsSem 7
BP801TBiostatistics & Research Methodology
  • Unit I: Data types, frequency distribution, measures of central tendency
  • Unit II: Parametric tests — t-test, ANOVA, z-test
  • Unit III: Non-parametric tests — chi-square, Mann-Whitney, Kruskal-Wallis
  • Unit IV: Correlation, regression, clinical trial design phases
  • Unit V: Research methodology — literature review, ethics, protocol writing
45 HrsSem 8
BP802TSocial & Preventive Pharmacy
  • Unit I: Health education, nutrition, epidemiology basics
  • Unit II: National health programs — RNTCP, NACP, NHM
  • Unit III: Essential medicines, rational drug use, pharmacoeconomics
  • Unit IV: Vaccines schedule, immunization programs, cold chain
  • Unit V: Patient compliance, medication errors, medication review
45 HrsSem 8
Visual Learning

Diagrams, Mnemonics & Flowcharts

Glycolysis — Step-by-Step Flowchart
Glucose (6C) ATP→ADP Glucose-6-phosphate Fructose-6-phosphate ATP→ADP Fructose-1,6-bisphosphate Aldolase ↓ DHAP (3C) G3P (3C) TPI 1,3-Bisphosphoglycerate ADP→ATP x2 3-Phosphoglycerate Pyruvate x2 Net: 2 ATP + 2 NADH per glucose

Glycolysis — 10 steps, cytoplasm, net 2 ATP

Key Points

  • Energy investment phase: uses 2 ATP (steps 1 & 3)
  • Energy payoff phase: produces 4 ATP + 2 NADH
  • Irreversible steps: Hexokinase, PFK-1, Pyruvate kinase
  • Regulated by: PFK-1 (inhibited by ATP, citrate; activated by AMP)
Pharmacology Mnemonics
ADME
  • Absorption — Drug enters systemic circulation
  • Distribution — Drug spreads to tissues (Vd)
  • Metabolism — Biotransformation (liver CYP450)
  • Excretion — Elimination via kidney, bile
FLAT PEG
  • Furosemide — Loop diuretic
  • Lasix — Brand name furosemide
  • Acetazolamide — CA inhibitor diuretic
  • Thiazides — HCTZ, chlorothiazide
  • Potassium-sparing — spironolactone, amiloride
  • Ethacrynate — Another loop diuretic
  • Glomerular filtrate — all act on nephron
RIPE
  • Rifampicin — Inhibits RNA polymerase
  • Isoniazid (INH) — Inhibits mycolic acid synthesis
  • Pyrazinamide — Disrupts membrane potential
  • Ethambutol — Inhibits arabinosyl transferase
TCA Cycle — Krebs Cycle Diagram
Acetyl CoA Citrate (6C) Isocitrate CO2+NADH α-KG CO2+NADH Succinyl CoA+GTP Succinate FADH2 Fumarate →Malate Oxalo- acetate+NADH 3 NADH 1 FADH2 + 1 GTP 2 CO2 / turn

TCA Cycle — Mitochondrial matrix. Per turn: 3 NADH, 1 FADH2, 1 GTP, 2 CO2

Key Molecular Structures
Aspirin (Acetylsalicylic Acid) COOH O-COCH3 MW: 180.16 | COX inhibitor | NSAID Paracetamol (Acetaminophen) HO- NH-CO-CH3 MW: 151.16 | Analgesic/Antipyretic | No GI side effects Adrenaline (Epinephrine) HO HO CH(OH) CH2-NH-CH3 Catecholamine | α & β agonist | Emergency use Chiral center at C-1 | L-form biologically active

Key drug structures from Medicinal Chemistry I & II

Blood Coagulation Cascade
Extrinsic Pathway Intrinsic Pathway TF + VIIa XII→XIIa→XI→XIa Factor Xa + Va Prothrombinase Complex Prothrombin (II) Thrombin (IIa) Fibrinogen (I) Fibrin Clot XIIIa cross-links

Drug Targets

  • Warfarin — inhibits Vitamin K (factors II, VII, IX, X)
  • Heparin — activates antithrombin III → inactivates Xa & IIa
  • Aspirin — inhibits TXA2 (antiplatelet)
Michaelis-Menten Kinetics
Vmax Vmax/2 Km Michaelis-Menten Plot [S] Substrate Concentration Reaction Rate (V)
V = Vmax [S] / (Km + [S])
  • Km = [S] at half-maximal velocity (affinity measure)
  • Low Km = High affinity for substrate
  • Vmax = Maximum velocity (proportional to enzyme)
  • Lineweaver-Burk = 1/V vs 1/[S] for inhibitor type
Beta-Lactam Antibiotics — Structure & SAR
Penicillin Core Structure Thiazolidine S β-lactam C=O R-CO-NH- 6-aminopenicillanic acid (6-APA) COOH Mechanism of Action ▸ Inhibits transpeptidase (PBP) enzyme ▸ Prevents peptidoglycan cross-linking in cell wall ▸ Bactericidal — acts on dividing bacteria ▸ Resistance: β-lactamase enzyme opens β-lactam ring

SAR of Penicillins

  • β-lactam ring: Essential for activity
  • R group at 6-APA: Determines spectrum
  • Bulky R group (cloxacillin): Resistant to β-lactamase
  • Aminobenzyl R (ampicillin): Broad-spectrum
Pharmacokinetics Mnemonics
BCS Classes
  • Class I: High solubility, High permeability (Metoprolol)
  • Class II: Low solubility, High permeability (Griseofulvin)
  • Class III: High solubility, Low permeability (Atenolol)
  • Class IV: Low solubility, Low permeability (Furosemide)
KEY PK FORMULAE
  • Vd = Dose / Cp0 (volume of distribution)
  • CL = Ke x Vd (total body clearance)
  • t½ = 0.693 / Ke (half-life)
  • F = (AUCoral/AUCiv) x 100 (bioavailability)
  • Css = F x Dose / (CL x τ) (steady state)
CYP Inhibitors
  • SICKFACES mnemonic for CYP3A4 inhibitors:
  • Sodium valproate, Isoniazid, Cimetidine, Ketoconazole
  • Fluconazole, Amiodarone, Clarithromycin, Erythromycin
  • Sertraline (SSRIs), Grapefruit juice
Standard References

Recommended Books

Textbook of Medical Physiology
Guyton & Hall — HAP I & II
Harper's Illustrated Biochemistry
Murray & Granner — Biochemistry
Pharmaceutical Dosage Forms & Drug Delivery
Ansel et al. — Pharmaceutics I & II
Vogel's Quantitative Chemical Analysis
Mendham et al. — Pharmaceutical Analysis
Goodman & Gilman's Pharmacology
Laurence Brunton — Pharmacology I-III
Theory & Practice of Industrial Pharmacy
Lachman & Lieberman — Industrial Pharmacy
Organic Chemistry
Morrison, Boyd & Bhattacharjee — Org Chem I-III
Pharmacognosy & Phytochemistry
C.K. Kokate, A.P. Purohit, S.B. Gokhale
Robbins Pathologic Basis of Disease
Vinay Kumar et al. — Pathophysiology
Biopharmaceutics & Pharmacokinetics
D.M. Brahmankar & Sunil Jaiswal
Remington: Science & Practice of Pharmacy
Alfonso Gennaro — All subjects
Pharmacopoeia of India (IP)
Ministry of Health — Official Standards
Built-In Study Tool

The Pomodoro Timer

25-minute focused intervals. Perfect for memorizing drug mechanisms, reaction pathways, and unit-wise topics. Let the timer drive your B.Pharm success.

25mFocus
5mShort Break
15mLong Break
25:00 Focus Session
Notes Physiology II Semester 3

ERN

Read Notes

Search Notes

Search This Blog

Subjects

Subjects

Quick Links

  • Pharmacology→
  • Pharmaceutics→
  • Biochemistry→
  • Medicinal Chemistry→
  • Pharmacognosy→
  • Pathophysiology→
  • NDDS→
  • MCQ Bank→

Archives

Blog Archive

  • ▼  2026 (3)
    • ▼  March (1)
      • ERN
    • ►  February (2)
Stay Updated

New Notes Every Week

Get notified when new subject notes, MCQs and study resources are uploaded for B.Pharm AKTU.

V-Pharm

Comprehensive B.Pharm notes for AKTU Lucknow students. All 8 semesters, PCI Guidelines 2019-20. Built for excellence.

Year I-II

  • Anatomy & Physiology
  • Biochemistry
  • Pharmaceutics I
  • Pathophysiology
  • Microbiology

Year III-IV

  • Pharmacology I-III
  • Medicinal Chem I-III
  • Industrial Pharmacy
  • NDDS
  • Quality Assurance

Resources

  • MCQ Bank
  • Previous Year Papers
  • Mnemonics
  • Pomodoro Timer
  • About V-Pharm

© 2025 V-Pharm. AKTU B.Pharm 2019-20. All Rights Reserved.

Built with ♥ for pharmaceutical excellence.

PDF Viewer
Focus
25:00
Powered by Blogger.